Adult cystic fibrosis patients who need antibiotics for a pulmonary exacerbation may be at risk of overtreatment and undertreatment if the duration of treatment is stipulated in guidelines, an expert warns. Writing in a comment piece published in the Lancet Respiratory Medicine, Associate Professor Michael Stephen from the Department of Pulmonary and Critical Care at ...
Calling time on length of antibiotic treatment for exacerbations in CF
By Nicola Garrett
17 Jul 2018